USPH — U.S. Physical Therapy, Inc.

U.S. Physical Therapy (USPH) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: Physical therapy revenues reached $168.1 million, up 17.8% year-over-year, primarily driven by acquisitions.
• Patient Visits: Total clinic visits increased by 18% year-over-year, with an average of 32.2 visits per clinic per day, the highest for Q3 in company history.
• Gross Profit: Grew by 30%, with a mid-teens increase even when adjusted for prior year noise.
• Adjusted EBITDA: Increased by 13.2% to $23.9 million.
• Operating Margin: Physical therapy operating margin stood at 18.6%.
• Salaries and Related Costs: Decreased by $0.40 per visit compared to the previous year, marking the first decline since Q4 2023.

2. Strategic Updates and Business Highlights

• Facility Expansion: Added 84 net physical therapy facilities over the past year, contributing to strong volume growth.
• AI and Technology Initiatives: Implementing AI-driven documentation and semi-virtualization of front desk operations, targeting 200 facilities by year-end.
• Injury Prevention Business: Continued strong performance with mid-20s revenue growth, indicating confidence in this segment's future.
• Remote Therapeutic Monitoring: Anticipated positive impact from CMS updates in 2026, allowing for greater patient engagement and better outcomes.

3. Forward Guidance and Outlook

• Adjusted EBITDA Guidance: Reaffirmed for full-year 2025 in the range of $93 million to $97 million.
• Medicare Rate Update: Expected to provide a tailwind of at least 1.5% in 2026, with potential for higher based on remote therapeutic monitoring integration.
• De Novo Growth: Targeting 30 to 50 new facilities annually, with plans to accelerate growth through improved leadership and operational strategies.

4. Bad News, Challenges, or Points of Concern

• Medicare Headwinds: Ongoing challenges with Medicare reimbursement cuts, which have totaled over 11% over the past five years.
• Competitive Pressures: The market remains competitive with various providers, including small practices and hospital-based systems, impacting patient acquisition.
• Injury Prevention Margins: Slight decline in gross margins for the injury prevention segment due to a shift in client mix, although overall growth remains strong.
• Economic Pressures: No significant evidence of inflation impacting patient care duration, but ongoing monitoring is necessary.

5. Notable Q&A Insights

• Demand Environment: Demand for physical therapy remains strong, with slight fluctuations observed in monthly volumes.
• Recruitment and Retention: Investments in recruitment infrastructure have improved turnover rates, although the market for therapists remains competitive.
• Workers' Compensation: Revenue from workers' comp increased by 5%, with ongoing efforts to expand higher-rate contracts.
• Home-Care Visits: Primarily driven by the Metro acquisition, with favorable reimbursement rates in the Northeast contributing to growth.

Overall, USPH demonstrated robust growth in Q3 2025, driven by strategic acquisitions and operational efficiencies, while navigating challenges related to Medicare reimbursement and competitive market dynamics. The outlook for 2026 appears positive, with anticipated improvements in reimbursement and ongoing initiatives to enhance service delivery.